Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

被引：2

作者：

Cheng, Minfeng ^{[1
]}

Gu, Huaying ^{[1
]}

Zheng, Liangrong ^{[1
]}

Wang, Houliang ^{[1
]}

Zhong, Zhiyong ^{[1
]}

Wen, Shenglin ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Psychiat, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China

来源：

NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2016年 / 12卷

关键词：

clozapine; neuroleptic malignant syndrome; withdrawal effect; schizophrenia;

D O I：

10.2147/NDT.S103687

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Here, we report a female patient developing neuroleptic malignant syndrome following the use of a combination of clozapine and haloperidol. Subsequently, the patient presented withdrawal effects after an abrupt discontinuation of clozapine. Psychiatrists not aware of possible clozapine-withdrawal effects may misdiagnose as a part of the primary mental illness or as the initial symptoms worsening, if unrecognized.

引用

页码：695 / 697

页数：3

共 13 条

[1]

Ananth J, 2004, J CLIN PSYCHIAT, V65, P464

[2] NEUROLEPTIC MALIGNANT SYNDROME IN AN AIDS PATIENT - CLINICAL AND PATHOLOGICAL FINDINGS [J].

GABELLINI, AS ;

PEZZOLI, A ;

DEMASSIS, P ;

CASADEI, G ;

GRILLO, A ;

SACQUEGNA, T .

ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 15 (06) :293-295

[3]

Gambassi G, 2006, AGING CLIN EXP RES, V18, P266

[4]

Kawanishi Chiaki, 2003, Am J Pharmacogenomics, V3, P89, DOI 10.2165/00129785-200303020-00002

[5] Neuroleptic malignant syndrome and atypical antipsychotics: A brief review [J].

Khaldi, S. ;

Kornreich, C. ;

Choubani, Z. ;

Gourevitch, R. .

ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (06) :618-624

[6]

Lee J W, 1997, Ann Clin Psychiatry, V9, P165, DOI 10.3109/10401239709147792

[7] NEUROLEPTIC MALIGNANT SYNDROME WITH INTRAVENOUS HALOPERIDOL [J].

LEVITT, AJ ;

MIDHA, R ;

CRAVEN, JL .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1990, 35 (09) :789-789

[8] Sympathoadrenal hyperactivity and neuroleptic malignant syndrome [J].

Qureshi, NA ;

Al-Habeeb, TA .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (02) :310-311

[9] NEUROLEPTIC TOXICITY SYNDROMES - A CLINICAL SPECTRUM [J].

REILLY, JJ ;

CROWE, SF ;

LLOYD, JH .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1991, 25 (04) :499-505

[10] THE TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME - ARE DANTROLENE AND BROMOCRIPTINE USEFUL ADJUNCTS TO SUPPORTIVE CARE [J].

ROSEBUSH, PI ;

STEWART, T ;

MAZUREK, MF .

BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 :709-712

← 1 2 →